Journal Of Investigative Dermatology

Subscribe to Journal Of Investigative Dermatology feed
Journal of Investigative Dermatology RSS feed.
Updated: 1 hour 3 min ago

Interventions for actinic keratosis in non-scalp and non-face localizations: results from a systematic review with network meta-analysis

Mon, 2020-07-06 00:00
Myriad interventions are available for the treatment of actinic keratoses (AK) located on the face or scalp. However, lesions located outside the head and neck have received little attention until now. We aimed to synthesize the current knowledge of interventions for AK in non-scalp and non-face localizations. Randomized controlled trials (RCTs) reporting data for these localizations were searched in Medline, Embase, and the Cochrane library CENTRAL as well as in pertinent trial registers until 25 March 2020.

Bromodomain epigenetic protein promotes metastatic potential in melanoma cells via increased invasiveness and decreased macrophage-mediated phagocytosis

Sun, 2020-07-05 00:00
With the advent of molecular targeted therapy and immunotherapy, the 5-years survival rate of patients with metastatic melanoma has increased (Jenkins and Fisher, 2020). Despite recent treatment advances, defining novel therapeutic targets for melanoma is still an unmet medical need for patients with resistant to those targeted therapies or immunotherapy. Epigenetic regulators have emerged as therapeutic targets for cancer therapy, of which bromodomain extra-terminal (BET) family protein BRD4 is a key reader protein that recognizes acetylated lysine residues on chromatin.

Regulatory B10 Cells Increase After Rituximab Therapy But Not After Conventional Immunosuppression In Patients With Pemphigus

Fri, 2020-07-03 00:00
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are rare diseases mediated by IgG autoantibody-induced damage of the skin (Kasperkiewicz et al., 2017). These diseases are commonly treated with high-dose systemic corticosteroids. However, patients can have difficulty stopping systemic corticosteroid treatments and often require additional adjunctive immunosuppression, including azathioprine, mycophenolate mofetil, or methotrexate. Rituximab, a monoclonal antibody directed against CD20 on B cells, is an effective first line therapy for patients with pemphigus when compared with prednisone treatment alone, with clinical responses persisting even after B cell recovery (Joly et al.

IL1α, IL6 and GMCSF, are Downstream Mediators of IL17A that Promote Asymmetric Stem Cell Self-Renewal in Human Keratinocytes

Wed, 2020-07-01 00:00
Interleukin 17A (IL17A), a key cytokine in the inflammation of psoriasis, is upregulated in psoriatic skin and stimulates transcriptional activity correlating with the psoriasis transcriptome (Chiricozzi et al., 2011). Asymmetric stem cell self-renewal (ASR) is increased in psoriasis. IL17A increases ASR in human keratinocytes and ASR divisions are IL17A-dependent in the imiquimod-induced-psoriasis-like mouse model (Charruyer et al., 2017).

The possible linkage of granzyme B-producing skin T cells with the disease prognosis of alopecia areata

Wed, 2020-07-01 00:00
Granzyme B-producing CD49a+ CD8 T cells in the lesional skin may reflect the disease prognosis in alopecia areata.

Late-Breaking Abstract Keyword List

Wed, 2020-07-01 00:00
AcneLB938, LB946

Late-Breaking Abstracts Author

Wed, 2020-07-01 00:00
Alakel, AkramLB950

Late-Breaking Abstracts Title Page

Wed, 2020-07-01 00:00
Society for Investigative Dermatology 2020

LB974 Donor-derived T cells accumulate in skin during resolution of acute GVHD

Wed, 2020-07-01 00:00
Graft-versus-host disease is a significant cause of morbidity and mortality following stem cell transplantation. Donor T cells are believed to be the main mediators of disease, however we recently identified that host T cells survive stem cell transplant conditioning and are present in high percentages in skin during active acute GVHD. Host T cells appear to contribute to disease pathology in both human studies and a humanized mouse model. Data further suggested that after resolution of acute GVHD, T cell chimerism in skin shift dramatically to donor T cells.

LB973 Immunologic profiling of fixed drug eruptions

Wed, 2020-07-01 00:00
Fixed drug eruptions (FDE) are a unique form of drug reaction in which a rash recurs at the same skin site(s) with each repeated drug exposure. This intriguing reaction has been postulated to be due to skin resident memory T cells, yet investigation into T cell phenotype and function and the concomitant inflammatory milieu are surprisingly limited. To elucidate disease pathobiology, we performed Nanostring transcriptional profiling on RNA extracted from formalin fixed paraffin embedded skin specimens of active FDE lesions and healthy control skin.

LB972 IL-17 inhibitor-induced remission of guttate psoriasis

Wed, 2020-07-01 00:00
Effective, targeted treatments for guttate psoriasis are lacking. Drugs that block the interleukin-17 (IL-17) pathway are highly effective in the treatment of plaque psoriasis. Given the overlap of immunopathogenic features between guttate and plaque psoriasis, including an over activation of Th17 cells, it is plausible that IL-17A inhibition would be an effective treatment for guttate psoriasis. Ixekizumab, a humanized IgG4 monoclonal antibody that targets interleukin-17A (IL-17A) is FDA-approved for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy, but to our knowledge has never been reported in the treatment of guttate psoriasis.

LB971 Type I and II interferon signaling differentially associated with histopathologic findings in dermatomyositis skin

Wed, 2020-07-01 00:00
Upregulation of interferon (IFN) signaling is well documented in the skin, as well as blood and muscle of dermatomyositis (DM) patients. However, it is unclear if IFN signaling is related to the pathologic features commonly found in DM skin biopsies. Here, we investigate the association of Type I and II IFN gene signatures with cardinal histologic findings seen in DM skin to better understand the contribution of IFN signaling to key pathological features of DM. Histological staining and RNA sequencing were performed on 113 skin biopsies from 99 patients with DM.

LB970 Dermoscopy during treatment of early Mycosis Fungoides

Wed, 2020-07-01 00:00
The type of dermoscopy pattern in post-therapy remaining plaques of early Mycosis Fungoides, might help physicians in selecting the most appropriate therapeutic measures. Dermoscopy is a noninvasive popular technique enhancing the diagnostic ability in Derrmatological practice. “Spermatozoa-like” structures and fine short linear vessels are the most specific dermoscopic diagnostic features of early Mycosis Fungoides. Little is known about their modification following treatment. In a pilot study we prospectively investigated the modifications, if any, of dermoscopy features in 8 patients, who had been treated for at least 1 year.

LB969 Analysis of epidermal gene expression profiles in patients with allergic contact dermatitis using non-invasive skin tape stripping

Wed, 2020-07-01 00:00
Allergic contact dermatitis (ACD) affects 20% of patients and combined with irritant contact dermatitis (ICD) account for more than 90% of occupational skin diseases. Patch testing is the gold standard for diagnosis of ACD but result interpretation may be patient and physician dependent. The purpose of this study is to examine whether noninvasive tape stripping can be used to differentiate ACD, ICD, and normal skin. We examined 39 immune and barrier genes expressed in various skin layers. Patients referred to the Massachusetts General Hospital Contact Dermatitis Clinic with confirmed diagnosis of ACD through patch testing were recruited.

LB968 Inhibition of sonic hedgehog signalling via MAPK activation controls chemotherapy-induced alopecia

Wed, 2020-07-01 00:00
Chemotherapy-induced hair loss (alopecia, CIA) remains a major unsolved problem in clinical oncology. CIA is often considered to be a consequence of the anti-mitotic and apoptosis-promoting properties of chemotherapy drugs acting on rapidly proliferating hair matrix keratinocytes. Here we show that in a mouse model of CIA, down-regulation of Shh signalling in the hair matrix is a critical early event. Inhibition of Shh signalling recapitulated key morphological and functional features of CIA, whereas recombinant Shh protein partially rescued hair loss.

LB967 Hemorrhagic complications in outpatient dermatological surgery

Wed, 2020-07-01 00:00
The increasing incidence of cutaneous neoplasms in the Caucasian population of the United States has made Mohs micrographic surgery (MMS) and surgical excision with wide margins the standard of care for the treatment of melanoma and non-melanoma skin cancers. These commonly performed surgical modalities promote high cure rates and conservative treatment methods, sparing the maximal amount of normal tissue. Although there is a growing body of evidence regarding the efficacy of dermatological surgery for the removal of cutaneous malignancies, there is still some debate regarding the guidelines for maintaining safety and avoiding complications of MMS and other dermatologic procedures.

LB966 Transcriptional regulation of migrating-keratinocyte adhesion during cutaneous wound healing

Wed, 2020-07-01 00:00
The migration of wound-edge keratinocytes is part of the wound response, crucial for complete wound closure. Despite significant advances, the molecular mechanisms that orchestrate cell-cell adhesion between migrating keratinocytes are not fully characterized. During wound re-epithelization, keratinocytes at the wound edge undergo series of cellular modifications. These cellular modifications require a loosening of cell-cell adhesion for effective migration. Mice lacking the epidermal transcription factor Grainyhead Like-3 (GRHL3) exhibit impaired wound healing and an increased adhesion between keratinocytes at the wound edge.

LB965 Follicular trochanters: A potential mechanism for stem cell depletion in scarring alopecia

Wed, 2020-07-01 00:00
The follicular bulge is a stem cell niche where the outer root sheath (ORS) abuts the arrector pili muscle insertion site in both murine and human hair follicles. Prior studies have recognized an uncommon structure termed the “follicular trochanter” which was described as an epithelial protrusion of the outer root sheath in anagen follicles. It has been shown that these structures prominently express keratin 15, a stem cell marker. We sought to determine if trochanters embedded in the fibrotic stroma contribute to follicular scarring in cicatricial alopecias.

LB963 Perceptions of clinical trials among patients with atopic dermatitis: An analysis by race

Wed, 2020-07-01 00:00
There is a lack of diversity among participants in dermatologic clinical trials. In order to gain an understanding of reasons for poor racial/ethnic diversity in dermatologic clinical trials, we performed a qualitative pilot study of adults with atopic dermatitis (AD) to identify their perceptions of clinical trials. We performed semi-structured interviews of 26 adults with AD. We used a purposive sampling approach to enroll a similar number of white (N=8), black (N=8), and Asian (N=9) adults. Interview responses were independently coded by two research assistants using a grounded theory approach.

LB962 Evaluation of time of presentation of central centrifugal cicatricial alopecia and outcomes of disease

Wed, 2020-07-01 00:00
Background: Central centrifugal cicatricial alopecia (CCCA) is a form of scarring hair loss that predominantly affects women of African descent. Although the etiology remains unknown, the pathogenesis involves inflammatory mediated destruction of the hair follicles. The management of CCCA is approached symptomatically rather than through evidence-based recommendations. Since treatment options do not provide a cure and are only aimed at halting disease progression, it is important to understand how time to presentation and symptomatology relates to treatment outcomes.